Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Invisible:
news
Video: Type 2 Diabetes Virtual Wellness Summit
🌟 Beyond Type 2’s Virtual Summit! 🌟 Watch the recording of our first Type 2 Diabetes Virtual Summit, an event that’s one of the industry’s first for people impacted by type 2 d...
Rezdiffra Approved for MASH—A Diabetes-related Liver Disease
On March 14, 2024, the U.S. Food and Drug Administration approved resmetirom (Rezdiffra)—the first drug for a diabetes-related liver disease known as MASH. The approval makes way for the first and o...
Dexcom Introduces Direct-to-Apple-Watch Feature for its G7 CGM
Dexcom recently introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users. This means G7 will be the only CGM system that can directly connect to Apple Watch—witho...
Payment Assistance and Savings Program Extended for the Eversense E3 CGM
Ascensia Diabetes Care and Senseonics have extended their Eversense Payment Assistance and Simple Savings (PASS) program—aimed to help people in the U.S. more affordably access the Eversense E3 cont...
ATTD 2022 Coverage: Advanced Technologies + Treatments for Diabetes
ATTD's annual conference covers the latest in diabetes technology and treatment. This year's event is in Barcelona from April 27-30, 2022.
Stelo Becomes the First Over-the-Counter Glucose Biosensor in the U.S.
On March 5, 2024, Dexcom, Inc. announced that the FDA has cleared Stelo to become the first over-the-counter glucose biosensor in the United States. Stelo, which is indicated for persons 18 and older,...
ADA Standards of Care 2024: So What’s New?
Diabetes research, technology, and treatments are rapidly changing. Here's what you need to know about the 2024 Standards of Care.
American Diabetes Association’s 81st Annual Scientific Sessions: #ADA2021
The biggest diabetes conference of the year is virtual for the second year + Beyond Type 2 is reporting live! Keep up with our coverage here.
Breaking News from ADA 2021
Breaking news from the biggest diabetes conference of the year - the American Diabetes Association's 81st Scientific Sessions.
Zepbound: A New Medication for Chronic Weight Management
Learn more about Zepbound, the latest medication to receive FDA approval for the treatment of obesity or weight-related medical problems.
Posts navigation
←
Newer
Posts
1
2
…
20
Older
Posts
→